# Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801

> **NCT01604746** · PHASE3 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 1146 (actual)

## Conditions studied

- Prophylaxis of Ross River Virus Infection

## Interventions

- **BIOLOGICAL:** Ross River Virus (RRV) Vaccine

## Key facts

- **NCT ID:** NCT01604746
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 1146 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01604746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01604746, "Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01604746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*